Amunix

Sanofi shrinks $6B biobucks deal with IGM

Sanofi is shrinking a collaboration with IGM Biosciences by half, shedding three cancer targets to focus on three immunology and inflammation targets.

Gabrielle Masson Apr 17, 2024 11:05am

Sanofi gambles $1B upfront on preclinical oncology biotech

Dec 21, 2021 7:25am

Amunix scores $117M to fuel T-cell engagers, cytokines

Mar 4, 2021 9:30am

ESMO: Amunix's T-cell engagers shrink solid tumors in animals

Sep 17, 2020 10:35am